The results show that SMYH can inhibit the protein expression of HIF1α/PPAR signalling pathway-related proteins and activate the PKA signalling pathway, thereby alleviating energy metabolism disorders in rats with myocardial hypertrophy. The gene discussed is PPARA; the disease is Disorder of energy metabolism.